The virtual liver: A multidisciplinary, multilevel challenge for systems biology

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 4, Issue 3, 2012, Pages 221-235

  Holzhütter, Hermann Georg ^a   Drasdo, Dirk ^b   Preusser, Tobias ^c   Lippert, Jörg ^d   Henney, Adriano M ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INRIA ROCQUENCOURT   (France)

^c JACOBS UNIVERSITY BREMEN   (Germany)

^d BAYER AG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEPCIDIN; INTERLEUKIN 10;

ALCOHOL CONSUMPTION; ARTICLE; BIOLOGICAL MODEL; CELL COMPARTMENTALIZATION; CELL CONTACT; COMPUTER ASSISTED TOMOGRAPHY; FEEDBACK SYSTEM; HEALTH CARE COST; HUMAN; KUPFFER CELL; LIVER; LIVER CELL; LIVER FUNCTION; LIVER PERFUSION; LIVER PRESERVATION; LIVER REGENERATION; LIVER RESECTION; LIVER STRUCTURE; MOLECULAR DYNAMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN SYNTHESIS; STELLATE CELL; SYSTEMIC CIRCULATION;

EID: 84859840179     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.1158     Document Type: Article

References (74)

1. Heinrich R, Schuster S, Holzhutter HG. Mathematical analysis of enzymic reaction systems using optimization principles. Eur J Biochem 1991, 201:1-21.
2. Kim TH, Kim J, Heslop-Harrison P, Cho KH. Evolutionary design principles and functional characteristics based on kingdom-specific network motifs. Bioinformatics 2010, 27:245-251.
3. Kolodkin AN, Bruggeman FJ, Plant N, Mone MJ, Bakker BM, Campbell MJ, van Leeuwen JP, Carlberg C, Snoep JL, Westerhoff HV. Design principles of nuclear receptor signaling: how complex networking improves signal transduction. Mol Syst Biol 2010, 6:446.
4. Salvado B, Karathia H, Chimenos AU, Vilaprinyo E, Omholt S, Sorribas A, Alves R. Methods for and results from the study of design principles in molecular systems. Math Biosci 2011, 231:3-18.
5. Henrich S, Richter S, Wade RC. On the use of PIPSA to guide target-selective drug design. ChemMedChem 2008, 3:413-417.
6. Magni G, Di Stefano M, Orsomando G, Raffaelli N, Ruggieri S. NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem 2009, 16:1372-1390.
7. Sivachenko A, Kalinin A, Yuryev A. Pathway analysis for design of promiscuous drugs and selective drug mixtures. Curr Drug Discov Technol 2006, 3:269-277.
8. Westerhoff HV, Kolodkin A, Conradie R, Wilkinson SJ, Bruggeman FJ, Krab K, van Schuppen JH, Hardin H, Bakker BM, Mone MJ, et al. Systems biology towards life in silico: mathematics of the control of living cells. J Math Biol 2009, 58:7-34.
9. Webster D, Muller R. In silico models of bone remodeling from macro to nano-from organ to cell. Wiley Interdiscip Rev Syst Biol Med 2010, 3:241-251.
10. Bassingthwaighte J, Hunter P, Noble D. The cardiac physiome: perspectives for the future. Exp Physiol 2009, 94:597-605.
11. Hunter P, Robbins P, Noble D. The IUPS human physiome project. Pflugers Arch 2002, 445:1-9.
12. Hunter PJ, Crampin EJ, Nielsen PM. Bioinformatics, multiscale modeling and the IUPS physiome project. Brief Bioinform 2008, 9:333-343.
13. Walser B, Stebbins CL. Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise. Eur J Appl Physiol 2008, 104:455-461.
14. Montgomery H, Brull D, Humphries SE. Analysis of gene-environment interactions by "stressing-the-genotype" studies: the angiotensin converting enzyme and exercise-induced left ventricular hypertrophy as an example. Ital Heart J 2002, 3:10-14.
15. Kung JW, Currie IS, Forbes SJ, Ross JA. Liver development, regeneration, and carcinogenesis. J Biomed Biotechnol 2009, 2010:8.
16. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010, 176:2-13.
17. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365:1415-1428.
18. Baumeister SE, Volzke H, Marschall P, John U, Schmidt CO, Flessa S, Alte D. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 2008, 134:85-94.
19. Jungerman K. Metabolic zonation of liver parenchyma. Semin Liver Dis 1988, 8:329-341.
20. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000, 31:255-260.
21. Del Conte-Zerial P, Brusch L, Rink JC, Collinet C, Kalaidzidis Y, Zerial M, Deutsch A. Membrane identity and GTPase cascades regulated by toggle and cut-out switches. Mol Syst Biol 2008, 4:206.
22. Ahmed MH, Abu EO, Byrne CD. Non-alcoholic fatty liver disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Prim Care Diabetes 2010, 4:129-137.
23. Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 2010, 9:42.
24. Ayton GS, Noid WG, Voth GA. Multiscale modeling of biomolecular systems: in serial and in parallel. Curr Opin Struct Biol 2007, 17:192-198.
25. Cerutti S, Hoyer D, Voss A. Multiscale, multiorgan and multivariate complexity analyses of cardiovascular regulation. Philos Transact A Math Phys Eng Sci 2009, 367:1337-1358.
26. Grima R. Multiscale modeling of biological pattern formation. Curr Top Dev Biol 2008, 81:435-460.
27. Meier-Schellersheim M, Fraser ID, Klauschen F. Multiscale modeling for biologists. Wiley Interdiscip Rev Syst Biol Med 2009, 1:4-14.
28. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003, 125: 178-191.
29. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007, 131:1728-1734.
30. Bartel T, Holzhutter HG. Mathematical modelling of the purine metabolism of the rat liver. Biochim Biophys Acta 1990, 1035:331-339.
31. Beard DA, Qian H. Thermodynamic-based computational profiling of cellular regulatory control in hepatocyte metabolism. Am J Physiol Endocrinol Metab 2005, 288:E633-E644.
32. Chalhoub E, Hanson RW, Belovich JM. A computer model of gluconeogenesis and lipid metabolism in the perfused liver. Am J Physiol Endocrinol Metab 2007, 293:E1676-E1686.
33. Ohno H, Naito Y, Nakajima H, Tomita M. Construction of a biological tissue model based on a single-cell model: a computer simulation of metabolic heterogeneity in the liver lobule. Artif Life 2008, 14:3-28.
34. Stucki JW, Urbanczik R. Pyruvate metabolism in rat liver mitochondria. What is optimized at steady state? Febs J 2005, 272:6244-6253.
35. Charalabopoulos K, Peschos D, Zoganas L, Bablekos G, Golias C, Charalabopoulos A, Stagikas D, Karakosta A, Papathanasopoulos A, Karachalios G, et al. Alterations in arterial blood parameters in patients with liver cirrhosis and ascites. Int J Med Sci 2007, 4:94-97.
36. Rijzewijk LJ, van der Meer RW, Lubberink M, Lamb HJ, Romijn JA, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, et al. Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes 2010, 59:2747-2754.
37. Price PS, Conolly RB, Chaisson CF, Gross EA, Young JS, Mathis ET, Tedder DR. Modeling interindividual variation in physiological factors used in PBPK models of humans. Crit Rev Toxicol 2003, 33:469-503.
38. Thompson CM, Johns DO, Sonawane B, Barton HA, Hattis D, Tardif R, Krishnan K. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. J Toxicol Environ Health B Crit Rev 2009, 12:1-24.
39. Willmann S, Hohn K, Edginton A, Sevestre M, Solodenko J, Weiss W, Lippert J, Schmitt W. Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn 2007, 34:401-431.
40. Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB. A physiological model for the estimation of the fraction dose absorbed in humans. J Med Chem 2004, 47:4022-4031.
41. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010, 2: 27ra27.
42. Eissing T, Kuepfer L, Becker C, Block M, Coboeken K, Gaub T, Goerlitz L, Jaeger J, Loosen R, Ludewig B, et al. A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks. Front Physiol 2011, 2:4.
43. Chen G, Li XC, Wu GQ, Zhang SX, Xiong XF, Tan LW, Yang RG, Li K, Yang SZ, Dong JH. Three-dimensional reconstruction of digitized human liver: based on Chinese visible human. Chin Med J (Engl) 2010, 123:146-150.
44. Bonfiglio A, Leungchavaphongse K, Repetto R, Siggers JH. Mathematical modeling of the circulation in the liver lobule. J Biomech Eng 2010, 132:111011.
45. Ricken T, Dahmen U, Dirsch O. A biphasic model for sinusoidal liver perfusion remodeling after outflow obstruction. Biomech Model Mechanobiol 9:435-450.
46. Georg M, Preusser T, Hahn H-K, eds. Global Constructive Optimization of Vascular Systems. 2010. Available at: http://cse.wustl.edu/Research/Lists/Technical%20 Reports/Attachments/910/idealvessel-1.pdf.
47. Schreiner W. Computer generation of complex arterial tree models. J Biomed Eng 1993, 15:148-150.
48. Hoehme S, Brulport M, Bauer A, Bedawy E, Schormann W, Hermes M, Puppe V, Gebhardt R, Zellmer S, Schwarz M, et al. Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A 2010, 107:10371-10376.
49. Papp V, Dezso K, Laszlo V, Nagy P, Paku S. Architectural changes during regenerative and ontogenic liver growth in the rat. Liver Transpl 2009, 15:177-183.
50. Drasdo D, Hoehme S, Block M. On the role of physics in the growth and pattern formation of multi-cellular systems:what can we learn from individual-cell based models? J Stat Phys 2007, 128:287-345.
51. Newman TJ. Modeling multicellular systems using subcellular elements. Math Biosci Eng 2005, 2:613-624.
52. Jamali Y, Azimi M, Mofrad MR. A sub-cellular viscoelastic model for cell population mechanics. PLoS ONE 2010, 5:e12097. doi:10.1371/journal.pone. 0012097.
53. Chen N, Glazier JA, Izaguirre JA, Alber MS. A parallel implementation of the cellular potts model for simulation of cell-based morphogenesis. Comput Phys Commun 2007, 176:670-681.
54. Thorne BC, Bailey AM, DeSimone DW, Peirce SM. Agent-based modeling of multicell morphogenic processes during development. Birth Defects Res C Embryo Today 2007, 81:344-353.
55. Ramis-Conde I, Drasdo D, Anderson AR, Chaplain MA. Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach. Biophys J 2008, 95:155-165.
56. Chu YS, Dufour S, Thiery JP, Perez E, Pincet F. Johnson-Kendall-Roberts theory applied to living cells. Phys Rev Lett 2005, 94:028102.
57. Rotstein J, Macdonald PD, Rabes HM, Farber E. Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis. Cancer Res 1984, 44:2913-2917.
58. Saarinen J, Saarelainen R, Lindros KO. A rapid method to study heterogeneous gene expression in liver by direct assay of messenger RNA from periportal and perivenous cell lysates. Hepatology 1993, 17:466-469.
59. Scheibe TD, Tartakovsky AM, Tartakovsky DM, Redden GD, Meakin P. Hybrid numerical methods for multiscale simulations of subsurface biogeochemical processes. J Phys Conf Ser 2007, 78:012063.
60. Gabriel E, Fagg GE, Bosilca G, Angskun T, Dongarra J, Squyres JM, Sahay V, Kambadur P, Barrett B, Lumsdaine A, et al. OpenMPI: Goals, concept, and design of a next generation. Proceedings 11th European PVM/MPI Users' Group Meeting, Budapest, Hungary, September 2004, 97-104.
61. Pope B, Fitch B, Pitman M, Rice J, Reumann M. Performance of Hybrid Programming Models for Multiscale, Cardiac Simulations: Preparing for Petascale Computation, IEEE Trans Biomed Eng, 2011.
62. Anderson J, Chang YC, Papachristodoulou A. Model decomposition and reduction tools for large-scale networks in systems biology. Automatica. 2011, 47:1165-1174.
63. Randhawa R, Shaffer CA, Tyson JJ. Model aggregation: a building-block approach to creating large macromolecular regulatory networks. Bioinformatics 2009, 25:3289-3295.
64. Clarke SD. Rapid changes in chick liver acetyl-CoA carboxylase indicative of phosphorylation control. Biochem Biophys Res Commun 1983, 116:633-638.
65. Gronowski AM, Rotwein P. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. J Biol Chem 1994, 269:7874-7878.
66. Dano S, Madsen MF, Schmidt H, Cedersund G. Reduction of a biochemical model with preservation of its basic dynamic properties. Febs J 2006, 273:4862-4877.
67. de Prony GR. Essai éxperimental et analytique: sur les lois de la dilatabilité de fluides élastique et sur celles de la force expansive de la vapeur de l'alkool, à différentes températures. Jl de l'école Polytechnique 1795, 1:24-76.
68. Ropers D, Baldazzi V, de Jong H. Model reduction using piecewise-linear approximations preserves dynamic properties of the carbon starvation response in Escherichia coli. IEEE/ACM Trans Comput Biol Bioinform 8:166-181.
69. Häussinger D. Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur J Biochem 1983, 133:269-275.
70. Gebhardt R, Baldysiak-Figiel A, Krugel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007, 41:201-266.
71. Hoehme S, Drasdo D. A cell-based simulation software for multi-cellular systems. Bioinformatics 2010, 26:2641-2642.
72. Hood L, Perlmutter RM. The impact of systems approaches on biological problems in drug discovery. Nature Biotechnol 2004, 22:1215-1217.
73. Henney A, Superti-Furga G. A network solution. Nature 2008, 455:730-731.
74. Henney AM. Who will take up the gauntlet? Challenges and opportunites for systems biollogy and drug discovery. EMBO Rep 2009, 10:S9-S13.